Amphastar Pharmaceuticals, Inc.
AMPHNASDAQHealthcare● Active
$19.39
$-0.35(-1.77%)
Market Cap$854961699
P/E Ratio—
52W High$31.26
52W Low$16.65
Amphastar Pharmaceuticals, Inc. (AMPH) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AMPH · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.28B | $0.22B | $0.26B | $0.18B | $0.14B |
| Net Receivables | $0.14B | $0.14B | $0.12B | $0.09B | $0.08B |
| Inventory | $0.18B | $0.15B | $0.11B | $0.10B | $0.09B |
| Total Current Assets | $0.64B | $0.53B | $0.49B | $0.38B | $0.32B |
| PP&E Net | $0.35B | $0.34B | $0.32B | $0.26B | $0.27B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.56B | $0.59B | $0.61B | $0.03B | $0.04B |
| Total Assets | $1.63B | $1.58B | $1.51B | $0.74B | $0.67B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.03B | $0.03B | $0.03B | $0.02B | $0.02B |
| Total Current Liabilities | $0.16B | $0.17B | $0.23B | $0.09B | $0.10B |
| Long-Term Debt | $0.61B | $0.60B | $0.59B | $0.07B | $0.07B |
| Total Liabilities | $0.84B | $0.85B | $0.87B | $0.21B | $0.23B |
| Stockholders Equity | |||||
| Retained Earnings | $0.67B | $0.57B | $0.41B | $0.27B | $0.18B |
| Total Stockholders Equity | $0.79B | $0.73B | $0.64B | $0.53B | $0.45B |
| Total Liab & Equity(computed) | $1.63B | $1.58B | $1.51B | $0.74B | $0.67B |
| Debt Summary | |||||
| Total Debt | $0.66B | $0.65B | $0.62B | $0.10B | $0.10B |
| Net Debt | $0.49B | $0.50B | $0.48B | ($0.05B) | ($0.02B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Amphastar Pharmaceuticals, Inc. data
About Amphastar Pharmaceuticals, Inc. (AMPH) Balance Sheet
Amphastar Pharmaceuticals, Inc. (AMPH) balance sheet shows total assets of $1.63B with cash of $0.28B. Total liabilities are $0.84B, total debt $0.66B, and stockholders equity $0.79B.
Frequently asked questions
AMPH · 4 questionsAmphastar Pharmaceuticals, Inc. has total debt of $0.66B with net debt of $0.49B.
AMPH total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10